Aethlon Medical, Inc.
General ticker "AEMD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $5.7M
Aethlon Medical, Inc. does not follow the US Stock Market performance with the rate: -45.1%.
Estimated limits based on current volatility of 25.6%: low 0.51$, high 0.76$
Factors to consider:
- Current price 50.5% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [1.12$, 3.47$]
- 2025-03-31 to 2026-03-31 estimated range: [1.35$, 3.84$]
Financial Metrics affecting the AEMD estimates:
- Negative: Non-GAAP EPS, $ of -4.80 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -70.29 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -5.41 <= 3.85
Short-term AEMD quotes
Long-term AEMD plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $0.29MM | $0.57MM | $0.00MM |
| Operating Expenses | $10.72MM | $12.47MM | $12.64MM |
| Operating Income | $-10.42MM | $-11.90MM | $-12.64MM |
| Non-Operating Income | $0.00MM | $-0.13MM | $0.43MM |
| R&D Expense | $2.34MM | $2.75MM | $0.00MM |
| Income(Loss) | $-10.42MM | $-12.03MM | $-12.21MM |
| Profit(Loss) | $-10.42MM | $-12.03MM | $-12.21MM |
| Stockholders Equity | $17.13MM | $15.06MM | $5.77MM |
| Assets | $19.42MM | $17.51MM | $8.25MM |
| Operating Cash Flow | $-9.77MM | $-10.51MM | $-10.13MM |
| Capital expenditure | $0.35MM | $0.94MM | $0.25MM |
| Investing Cash Flow | $-0.35MM | $-0.94MM | $-0.25MM |
| Financing Cash Flow | $17.37MM | $8.91MM | $1.29MM |
| Earnings Per Share* | $-7.06 | $-5.86 | $-4.86 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.